Table of Contents
International Scholarly Research Notices
Volume 2014 (2014), Article ID 481059, 7 pages
http://dx.doi.org/10.1155/2014/481059
Research Article

Validation of a Stability-Indicating RP-HPLC Method for Determination of L-Carnitine in Tablets

Department of Pharmaceutics, Faculty of Pharmacy, Islamic Azad University (IAUPS), Pharmaceutical Sciences Branch, Tehran 193956466, Iran

Received 5 June 2014; Accepted 30 July 2014; Published 23 October 2014

Academic Editor: Josep Esteve-Romero

Copyright © 2014 Roghaieh Khoshkam and Minoo Afshar. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Dabrowska and M. Starek, “Analytical approaches to determination of carnitine in biological materials, foods and dietary supplements,” Food Chemistry, vol. 142, pp. 220–232, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Fu, M. Huang, and S. Chen, “Primary carnitine deficiency and cardiomyopathy,” Korean Circulation Journal, vol. 43, no. 12, pp. 785–792, 2013. View at Google Scholar
  3. F. de Andrés, G. Castañeda, and G. A. Ríos, “Achiral liquid chromatography with circular dichroism detection for the determination of carnitine enantiomers in dietary supplements and pharmaceutical formulations,” Journal of Pharmaceutical and Biomedical Analysis, vol. 51, no. 2, pp. 478–483, 2010. View at Google Scholar
  4. C. Mancuso, R. Siciliano, E. Barone, and P. Preziosi, “Natural substances and Alzheimer's disease: from preclinical studies to evidence based medicine,” Biochimica et Biophysica Acta, vol. 1822, no. 5, pp. 616–624, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Kakou, N. C. Megoulas, and M. A. Koupparis, “Determination of l-carnitine in food supplement formulations using ion-pair chromatography with indirect conductimetric detection,” Journal of Chromatography A, vol. 1069, no. 2, pp. 209–215, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. G.-X. He and T. Dahl, “Improved high-performance liquid chromatographic method for analysis of L-carnitine in pharmaceutical formulations,” Journal of Pharmaceutical and Biomedical Analysis, vol. 23, no. 2-3, pp. 315–321, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. P. de Witt, R. Deias, S. Muck et al., “High-performance liquid chromatography and capillary electrophoresis of L- and D-carnitine by precolumn diastereomeric derivatization,” Journal of Chromatography B: Biomedical Applications, vol. 657, no. 1, pp. 67–73, 1994. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Kamata, M. Takahashi, K. Terasima, and M. Nishijima, “Liquid chromatographic determination of carnitine by precolumn derivatization with pyrene-1-carbonyl cyanide,” Journal of Chromatography A, vol. 667, no. 1-2, pp. 113–118, 1994. View at Publisher · View at Google Scholar · View at Scopus
  9. R. N. El-Shaheny, “Evaluation of agomelatine stability under different stress conditions using an HPLC method with fluorescence detection: application to the analysis of tablets and human plasma,” Luminescence, 2014. View at Publisher · View at Google Scholar
  10. N. A. El-Ragehy, N. Y. Hassan, M. Abdelkawy, and M. A. Tantawy, “Stability-indicating chromatographic methods for the determination of sertindole,” Journal of Chromatographic Science, vol. 52, no. 6, pp. 559–565, 2014. View at Google Scholar
  11. FDA, Center for Drug Evaluation and Research (CDER), and Center for Biologics Evaluation and Research (CBER), “Guidance for industry. Analytical procedures and methods validation (Chemistry, Manufacturing, and Controls Documentation),” Rockville, Md, USA, 2000, http://www.fda.gov/downloads/Drugs/Guidances/ucm122858.pdf.
  12. ICH, “Harmonised tripartite guideline, stability testing of new drug substances and products Q1A (R2),” USA, 2003, http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q1A_R2/Step4/Q1A_R2__Guideline.pdf.
  13. ICH, “Harmonised tripartite guideline, stability testing: photostability testing of new drug substances and products Q1B, USA,” 1996, http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q1B/Step4/Q1B_Guideline.pdf.
  14. M. Bakshi and S. Singh, “Development of validated stability-indicating assay methods—critical review,” Journal of Pharmaceutical and Biomedical Analysis, vol. 28, no. 6, pp. 1011–1040, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. http://www.rxlist.com/carnitor-drug.htm.
  16. F. Sadeghi, L. Navidpour, S. Bayat, and M. Afshar, “Validation and uncertainty estimation of an ecofriendly and stability-indicating HPLC method for determination of diltiazem in pharmaceutical preparations,” Journal of Analytical Methods in Chemistry, vol. 2013, Article ID 353814, 10 pages, 2013. View at Publisher · View at Google Scholar
  17. J. Ermer and H.-J. Ploss, “Validation in pharmaceutical analysis: part II: central importance of precision to establish acceptance criteria and for verifying and improving the quality of analytical data,” Journal of Pharmaceutical and Biomedical Analysis, vol. 37, no. 5, pp. 859–870, 2005. View at Publisher · View at Google Scholar · View at Scopus